Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep479 | Pituitary and Neuroendocrinology | ECE2021

Metabolic profile in patients with prolactinoma before and on dopamine agonist therapy

Giuca Diandra Carmen , Trifanescu Raluca , Vere Cristin Constantin , Baciu Ionela , Baculescu Nicoleta , Capatina Cristina , Dusceac Roxana , Găloiu Simona Andreea , Niculescu Dan Alexandru , Radian Serban , Caragheorgheopol Andra , Schipor Sorina , Poiana Catalina

BackgroundProlactinomas are the most frequent type of hormone-secreting pituitary adenomas. Prolactin(PRL)-receptor mediates intracellular signaling pathways that contribute to weight gain, dyslipidemia, impaired fasting glucose (IFG), type 2 diabetes mellitus (T2DM) and cardiovascular disease, parameters that improve along with PRL level control on dopamine agonist (DA) therapy.AimTo assess metabolic disturb...